Related Experiment Videos

Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition

Nazarii Kobyliak1, Tetyana Falalyeyeva, Tetyana Beregova

  • 1Bogomolets National Medical University. nazariikobyliak@gmail.com.

Endokrynologia Polska
|October 13, 2017
PubMed

Insights

Multistrain probiotics significantly reduced obesity prevalence and improved lipid profiles in rats compared to single strains. Live multistrain probiotics demonstrated superior efficacy in managing obesity-related metabolic changes.

Area of Science:

  • Microbiology
  • Animal Nutrition
  • Metabolic Research

Background:

  • Obesity is a growing health concern with complex etiologies.
  • Monosodium glutamate (MSG) administration in neonates is a model for inducing obesity in animal studies.
  • Probiotics are being investigated for their potential role in managing obesity and metabolic disorders.

Purpose of the Study:

  • To comparatively evaluate the efficacy of single-strain, three-strain mix, and live multi-strain probiotics in an animal model of obesity.
  • To assess the impact of different probiotic formulations on obesity prevalence, visceral adipose tissue (VAT) weight, and serum lipid levels.

Main Methods:

  • A rat model of obesity was established using neonatal MSG injection.
  • Rats were divided into seven groups, including a control, MSG-obesity group, and groups treated with lyophilized single-strain probiotics, a three-strain mix, or a live multi-strain probiotic (Symbiter).
  • Efficacy was assessed by monitoring obesity prevalence, body weight, food consumption, VAT weight, and serum lipid levels.

Main Results:

  • Neonatal MSG treatment induced obesity in rats.
  • Probiotic administration, particularly live multi-strain formulations, significantly reduced obesity prevalence compared to single-strain probiotics.
  • Multi-strain probiotics led to greater reductions in VAT weight and serum lipid levels than single-strain probiotics, with L. casei IMVB-7280 showing a trend towards stronger hypolipidemic effects.

Conclusions:

  • Live multi-strain probiotics exhibit superior efficacy in combating obesity and associated metabolic dysregulation compared to single-strain probiotics.
  • The synergistic interactions among multiple probiotic strains contribute to enhanced health benefits.
  • Probiotic interventions hold promise for managing obesity and improving metabolic health.
Abstract

Related Concept Videos